Effects of Nebivolol on the walking distance in patients with essential hypertension and peripheral arterial occlusive disease (PAOD) Fontain's stage II- A randomized, double blind, multicenter, active substance controlled clinical trial phase III

Trial Profile

Effects of Nebivolol on the walking distance in patients with essential hypertension and peripheral arterial occlusive disease (PAOD) Fontain's stage II- A randomized, double blind, multicenter, active substance controlled clinical trial phase III

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Hydrochlorothiazide; Nebivolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors Menarini
  • Most Recent Events

    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top